New biomarkers for lung cancerJune 08, 2004Rubén P'o, researcher at the University of Navarre, has carried out a study of biomarkers for detecting lung cancer. In recognition of this work, he has been awarded the 2004-06 prize for applied lung cancer research by the American Association for Cancer Research and the Foundation for Research into and Prevention of Cancer. Of the thirty projects presented, ten received awards - nine of these by researchers based at North American institutions - and the researcher from Spain. The 100,000 dollar prize will be reinvested in continuing the study. For Rubén P'o, working in the biomarkers laboratory at CIMA (Applied Medicine Research Centre) of the University of Navarre, this is the second time he has been awarded an international prize this academic year; last autumn he won a young researchers award in Vancouver involving another project on lung cancer. Prime cause of death from cancer amongst adult males The work carried out by this Doctor of Pharmacy is aimed at finding biomarkers that detect lung cancer in its early stages, given that early diagnosis facilitates a cure in a high percentage of patients while amongst patients who have been diagnosed late there is a high mortality rate. Today, lung cancer is the principal cause of death from cancer amongst adult males. In the studies undertaken to date, Rubén P'o has found that patients with lung cancer may have present in the fluids of those respiratory tracts that have been in contact with the tumour, abnormally high quantities of a protein (complement factor H). | |||||||||||||||||||||
|
Related Lung Cancer Current Events and Lung Cancer News Articles Deaths from lung cancer could be reduced by better policies to control indoor radon About 1100 people each year die in the UK from lung cancer related to indoor radon, but current government protection policies focus mainly on the small number of homes with high radon levels and neglect the 95% of radon related deaths caused by lower levels of radon, according to a study published on bmj.com today. Cell Biologists Identify New Tumor Suppressor for Lung Cancer Cancer and cell biology experts at the University of Cincinnati (UC) have identified a new tumor suppressor that may help scientists develop more targeted drug therapies to combat lung cancer. In lung cancer, silencing one crucial gene disrupts normal functioning of genome While examining patterns of DNA modification in lung cancer, a team of international researchers has discovered what they say is a surprising new mechanism. Lung cancer cells activate inflammation to induce metastasis A research team from the University of California, San Diego School of Medicine has identified a protein produced by cancerous lung epithelial cells that enhances metastasis by stimulating the activity of inflammatory cells. Common food additive found to increase risk and speed spread of lung cancer New research in an animal model suggests that a diet high in inorganic phosphates, which are found in a variety of processed foods including meats, cheeses, beverages, and bakery products, might speed growth of lung cancer tumors and may even contribute to the development of those tumors in individuals predisposed to the disease. UT Southwestern researchers identify gene linked to inherited form of fatal lung disease Researchers at UT Southwestern Medical Center have determined that a mutation in a gene known for its role in defending the lungs against invading pathogens is responsible for some inherited cases of a lethal lung disease affecting older adults. The same mutation may also be associated with lung cancer, the researchers said. Genetic markers identified for alcohol response in UCSF Gallo study Researchers at the UCSF Ernest Gallo Clinic and Research Center have identified a region on the human genome that appears to determine how strongly drinkers feel the effects of alcohol and thus how prone they are to alcohol abuse. Research highlights new approaches to prevent blood clots Blood clotting, or coagulation, is an important process that prevents excessive bleeding when a blood vessel is injured. Drop in cancer deaths tied primarily to gains in behavior and screening Improvements in behavior and screening have contributed greatly to the 13 percent decline in cancer mortality since 1990, with better cancer treatments playing a supporting role, according to new research from David Cutler of Harvard University. Stanford blood scanner detects even faint indicators of cancer A team led by Stanford researchers has developed a prototype blood scanner that can find cancer markers in the bloodstream in early stages of the disease, potentially allowing for earlier treatment and dramatically improved chances of survival. More Lung Cancer Current Events and Lung Cancer News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||